MedWatch

Demant wins market shares: "We are a far bigger business now than before Covid-19"

The global hearing aid market is pretty much back to pre-pandemic levels, and the industry's Big Five are back at it in a zero-sum game. Currently GN Hearing loses market shares to its competitor Demant, according to the CEO of the latter company, Søren Nielsen.

Closed retailers, extensive production halts in factories, travel bans and restrictions. 2020 was truly annus horribilis for the hearing aid industry, whose primary customer segment – the oldest part of the population – largely shut the doors to the world, including to the audiologist's office.

Revenue and earnings dives were the inevitable consequences for most businesses, and so, too, for hearing aid group Demant, which like many others had to make heavy use of public financial support programs to keep heads above water.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs